Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Zebisch

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The FEBS Journal|October 7, 2009
The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor bindingAnja Hauburger, Sabrina von Einem, Gerburg K Schwaerzer, et al.
Nature Communications|November 15, 2013
Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondinMatthias Zebisch, Yang Xu, Christos Krastev, et al.
Developmental Cell|March 17, 2015
Notum is required for neural and head induction via Wnt deacylation, oxidation, and inactivationXinjun Zhang, Seong-Moon Cheong, Nathalia G Amado, et al.
Nature|March 4, 2015
Notum deacylates Wnt proteins to suppress signalling activitySatoshi Kakugawa, Paul F Langton, Matthias Zebisch, et al.
Acta Crystallographica. Section D, Structural Biology|May 15, 2026
A novel fusion tool to enable G protein-coupled receptor structure determinationNita R Shah, Mathieu Oosterlaken, Claudine Bisson, et al.
Protein Expression and Purification|November 22, 2020
Development of a robust crystallization platform for immune receptor TREM2 using a crystallization chaperone strategyNoel J Byrne, Amy C Lee, James Kostas, et al.
Communications Biology|July 31, 2023
Structural insights into selective small molecule activation of PKG1αEssam Metwally, Victor Mak, Aileen Soriano, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.
Journal of Medicinal Chemistry|July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral NeuropathyKang Le, Michael J Soth, Jason B Cross, et al.
Journal of Medicinal Chemistry|July 25, 2022
Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1αVictor W Mak, Akash M Patel, Rose Yen, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The FEBS Journal|October 7, 2009
The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor bindingAnja Hauburger, Sabrina von Einem, Gerburg K Schwaerzer, et al.
Nature Communications|November 15, 2013
Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondinMatthias Zebisch, Yang Xu, Christos Krastev, et al.
Developmental Cell|March 17, 2015
Notum is required for neural and head induction via Wnt deacylation, oxidation, and inactivationXinjun Zhang, Seong-Moon Cheong, Nathalia G Amado, et al.
Nature|March 4, 2015
Notum deacylates Wnt proteins to suppress signalling activitySatoshi Kakugawa, Paul F Langton, Matthias Zebisch, et al.
Acta Crystallographica. Section D, Structural Biology|May 15, 2026
A novel fusion tool to enable G protein-coupled receptor structure determinationNita R Shah, Mathieu Oosterlaken, Claudine Bisson, et al.
Protein Expression and Purification|November 22, 2020
Development of a robust crystallization platform for immune receptor TREM2 using a crystallization chaperone strategyNoel J Byrne, Amy C Lee, James Kostas, et al.
Communications Biology|July 31, 2023
Structural insights into selective small molecule activation of PKG1αEssam Metwally, Victor Mak, Aileen Soriano, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.
Journal of Medicinal Chemistry|July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral NeuropathyKang Le, Michael J Soth, Jason B Cross, et al.
Journal of Medicinal Chemistry|July 25, 2022
Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1αVictor W Mak, Akash M Patel, Rose Yen, et al.
Pageof 4